Pharmadrug Inc.
PHRX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -132.70K | -105.20K | -401.40K | -9.04M | -223.70K |
| Total Depreciation and Amortization | 9.20K | 9.20K | 9.30K | 19.30K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 4.40K |
| Total Other Non-Cash Items | 91.30K | 94.60K | 68.60K | 8.80M | 69.50K |
| Change in Net Operating Assets | 25.30K | -148.10K | -79.80K | 216.10K | 31.30K |
| Cash from Operations | -7.00K | -149.60K | -403.30K | -11.70K | -118.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 545.10K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -200.00 | 6.00K |
| Cash from Investing | -- | -- | -- | 544.80K | 6.00K |
| Total Debt Issued | -- | -- | -- | 100.00K | -- |
| Total Debt Repaid | -- | -- | -- | -96.00K | -- |
| Issuance of Common Stock | -- | -- | 326.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 221.50K | 300.00K |
| Cash from Financing | -- | -- | 241.80K | 165.80K | 223.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | 600.00 | 700.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -405.30K | -- |
| Net Change in Cash | -7.00K | -149.60K | -161.50K | 294.10K | 112.00K |
